Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China · Delayed Price · Currency is CNY

8.53

+0.43 (5.31%)

Sep 14, 2026, 3:00 PM CST

Market Cap	4.04B +17.3%
Revenue (ttm)	1.84B -3.1%
Net Income	27.40M -58.7%
EPS	0.05 -58.3%
Shares Out	534.07M
PE Ratio	161.85
Forward PE	n/a
Dividend	0.07 (0.78%)
Ex-Dividend Date	Jun 17, 2026

Volume	78,407,224
Open	8.08
Previous Close	8.10
Day's Range	7.92 - 8.65
52-Week Range	4.33 - 12.77
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1990

Employees 1,196

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600613

Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements